| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.INF.0000166154.47013.47 |
| P698 | PubMed publication ID | 15931137 |
| P50 | author | Kathryn M. Edwards | Q52577914 |
| P433 | issue | 6 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | S104-8 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
| P1476 | title | Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination | |
| P478 | volume | 24 |
| Q42848329 | A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults |
| Q36445527 | An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. |
| Q41547935 | Bordetella parapertussis outbreak in Bisham, Pakistan in 2009-2010: fallout of the 9/11 syndrome. |
| Q50991764 | Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection. |
| Q33628654 | Bordetella pertussis strains with increased toxin production associated with pertussis resurgence |
| Q36010403 | Characterization of the immune response induced by pertussis OMVs-based vaccine |
| Q30831791 | Children with pertussis inform the investigation of other pertussis cases among contacts |
| Q37583898 | Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US. |
| Q35666201 | Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays |
| Q41526557 | Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium |
| Q34345687 | Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand |
| Q37450840 | Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection |
| Q45242376 | Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005. |
| Q33840409 | Estimating Loss of Brucella Abortus Antibodies from Age-Specific Serological Data In Elk. |
| Q36319199 | Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants |
| Q39172609 | Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice |
| Q43611757 | Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine |
| Q81460063 | Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine |
| Q40403647 | Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age. |
| Q35122801 | Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine admi |
| Q40164989 | Implementation of pertussis immunization in health-care personnel |
| Q37410302 | Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study |
| Q35875902 | Increased risk of pertussis in patients with asthma |
| Q35820060 | Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data |
| Q36472999 | Infant pertussis and household transmission in Korea |
| Q64133350 | International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007 |
| Q36458388 | Is there a need for a new generation of vaccines against pertussis? |
| Q37130808 | Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial |
| Q37457004 | Levels of childhood vaccination coverage and the impact of maternal HIV status on child vaccination status in rural KwaZulu-Natal, South Africa*. |
| Q43781170 | Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. |
| Q38589021 | Maternal benefits of immunization during pregnancy |
| Q40297628 | Mathematical modeling of delayed pertussis vaccination in infants |
| Q35690445 | Multitarget PCR for diagnosis of pertussis and its clinical implications |
| Q40134637 | Pertussis Accompanying Recent Mycoplasma Infection in a 10-Year-Old Girl. |
| Q36277476 | Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008). |
| Q37055740 | Pertussis antibodies in postpartum women and their newborns |
| Q88359620 | Pertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation |
| Q36521834 | Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations |
| Q92089120 | Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting |
| Q38241405 | Pertussis in Latin America: epidemiology and control strategies |
| Q37794263 | Pertussis-The Case for Universal Vaccination |
| Q30251684 | Pertussis: Microbiology, Disease, Treatment, and Prevention |
| Q31159257 | Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data |
| Q39337495 | Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark |
| Q34465419 | Seroprevalence of pertussis in Senegal: a prospective study |
| Q46242316 | Synthesis of α-branched acyclic nucleoside phosphonates as potential inhibitors of bacterial adenylate cyclases |
| Q33564283 | T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis |
| Q37806198 | Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults |
| Q33412583 | The epidemiology of pertussis in Germany: past and present |
| Q82077275 | The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications? |
| Q41588991 | The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis |
| Q36811870 | Treating the immunocompetent patient who presents with an upper respiratory infection: pharyngitis, sinusitis, and bronchitis |
| Q36779361 | Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand |
| Q58112370 | Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review |
| Q34362988 | Update on pertussis and pertussis immunization |
| Q44939855 | Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials |
| Q26860740 | Vaccinations for pregnant women |
Search more.